Saturday 17 October 2026
Export MED’s income statement to Excel — free account
MEDIFAST INC
MED Consumer Cyclical Personal Services
MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.
11.88
0.18
−1.49%
Follow MED
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
683.50 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.35 | 0.30 | 0.32 | 0.37 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
12.40 | (22.22) | 431.35 | 69.62 | |
P/B ratio |
0.70 | 0.59 | 0.57 | 0.60 | |
Price to Tangible BV |
0.70 | 0.59 | 0.57 | 0.60 | |
EV/Sales |
0.04 | (0.03) | (0.05) | (0.04) | |
EV/EBITDA |
2.02 | 17.88 | 7.47 | 2.09 | |
EV/Operating CF |
2.12 | (1.67) | (4.92) | (1.50) | |
EV/FCF |
(0.58) | 0.45 | 0.74 | 0.68 | |
Quick Ratio |
3.71 | 4.01 | 4.13 | 4.21 | |
Current Ratio |
4.45 | 4.69 | 4.80 | 4.86 | |
Net Debt/EBITDA |
220.75 | 37.21 | (7,039.42) | 164.71 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.54 | 1.45 | 1.30 | 1.20 | |
Operating CF/Net income |
(5.36) | 0.29 | (0.12) | (0.55) | |
Capex/Depreciation |
(0.41) | (0.41) | 0.77 | (0.29) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
74.09% | 79.82% | 72.39% | 75.57% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1.02% | 2.89% | 2.49% | 2.38% | |
Graham Net Nets |
1.03 | 1.30 | 1.32 | 1.17 | |
Graham Number |
2.96 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
0.15% | (15.92%) | (17.86%) | (21.96%) | |
Free Cash Flow Yield |
(17.52%) | (21.93%) | (22.11%) | (16.35%) | |
Revenue per Share |
8.13 | 6.84 | 6.91 | 6.86 | |
Operating CF per Share |
1.10 | (0.48) | 0.02 | 0.15 | |
Capex per Share |
(0.12) | (0.12) | 0.23 | (0.09) | |
Free Cash Flow per Share |
0.98 | (0.60) | 0.25 | 0.07 | |
Cash per Share |
15.79 | 15.23 | 15.35 | 15.25 | |
Shareholders Equity per Share |
19.53 | 18.11 | 17.96 | 17.64 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.53 | 18.11 | 17.96 | 17.64 | |
Free Cash Flow |
10.75 | (6.63) | 2.80 | 0.73 | |
Working Capital |
161.13 | 158.72 | 160.45 | 160.47 | |
Capital Expenditures |
(1.36) | (1.35) | 2.54 | (0.97) | |
Net Current Asset Value |
154.34 | 152.63 | 148.27 | 138.01 | |
EV/EBIT |
0.00 | 0.81 | 1.12 | 0.67 | |
Capex to Sales |
0.02 | 0.02 | (0.03) | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 2.88 | 2.95 | 2.67 | |
Average Payables |
53.76 | 47.43 | 45.04 | 38.33 | |
Average Inventory |
31.65 | 31.32 | 30.38 | 25.69 | |
Average Assets |
279.72 | 266.09 | 266.03 | 264.87 | |
Average Common Equity |
211.02 | 204.51 | 204.32 | 206.19 |
Columns are period end dates